Unexpected candidemia complicating ureteroscopy and urinary stenting

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 8, 1998, Pages 583-586

  Gross, M ^a   Winkler, H ^a   Pitlik, S ^b   Weinberger, M ^b  

^a Beilinson Campus   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE;

AGED; ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ENDOPHTHALMITIS; FEMALE; FUNGEMIA; HUMAN; NEPHROLITHIASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URETER STENT; URETEROSCOPY; URINE CULTURE;

EID: 0031659407     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01708625     Document Type: Article

References (42)

1. Béck-Sague CM, Jarvis WR, the National Nosocomial Infection Surveillance System: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. Journal of Infectious Diseases (1993) 167:1247-1251
2. Fridkin SK, Jarvis WR: Epidemiology of nosocomial fungal infections. Clinical Microbiology Reviews (1996) 9:499-511
3. Jarvis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clinical Infectious Diseases (1995) 20:1526-1530
4. Bross J, Talbot GH, Maislin G, Hurwitz S, Storm BL: Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. American Journal of Medicine (1989) 87:614-619
5. Goodrich JM, Reed EC, Skerrett S, Mori M, Fisher LD, Dandliker PS, Kils B, Counts GW, Meyers JD: Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. Journal of Infectious Diseases (1991) 164:731-740
6. Karabinis A, Hill C, Leclercq B, Tancréde C, Baume D, Andremont A: Risk factors for candidemia in cancer patients: a case-control study. Journal of Clinical Microbiology (1988) 26:429-432
7. Richet HM, Andremont A, Tancréde C, Pico JL, Jarvis WR: Risk factors for candidemia in patients with acute lymphocytic leukemia. Reviews of Infectious Diseases (1991) 13:211-215
8. Weese-Mayer DE, Wheeler Fondriest D, Brouillette RT, Shulman ST: Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatric Infectious Disease Journal (1987) 6:190-196
9. Wenzel RP: Nosocomial candidemia: risk factors and attributable mortality. Clinical Infectious Diseases (1995) 20:1531-1534
10. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP: Risk factors for hospital-acquired candidemia. A matched case-control study. Archives of Internal Medicine (1988) 149:2349-2353
11. Nieto-Rodriguez JA, Kusne S, Maňez R, Irish W, Linden P, Mangone M, Wing EJ, Fung JJ, Starzl TE: Factors associated with the development of candidemia and candidetnia-related death among liver transplant recipients. Annals of Surgery (1996) 223:70-76
12. Carson CCI: Endourology. In: Glenn JF (ed): Urologic surgery. J.B. Lippincott, Philadelphia (1991) pp. 287-305
13. Saltzman B: Ureteral stents. Indication, variation, and complications. Urologic Clinics of North America (1988) 15:481-491
14. Sullivan NM, Sutter VL, Mims MM, Marsh VH, Finegold SM: Clinical aspects of bacteremia after manipulation of the genitourinary tract. Journal of Infectious Diseases (1973) 127:49-55
15. Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JEJ, Wagener MW, Yu VL: Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology (1994) 101:1302-1309
16. Nolla-Salas J, Sitges-Serra A, Leon C, de la Torre MV, Sancho H: Candida endophthalmitis in non-neutropenic critically ill patients. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:503-506
17. O-Day DM, Foulds G, Williams TE, Robinson RD, Allen RH, Head WS: Ocular uptake of fluconazole following oral administration. Archives of Ophthalmology (1990) 108:1006-1008
18. Akler ME, Vellend H, McNeely DM, Walmsley SL, Gold WL: Use of fluconazole in the treatment of candidal endophthalmitis. Clinical Infectious Diseases (1995) 20:657-664
19. Park SS, D'Amico DJ, Paton B, Baker AS: Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole. Antimicrobial Agents and Chemotherapy (1995) 39:958-963
20. Luttrull JK, Wan WL, Kubak BM, Smith MD, Oster HA: Treatment of ocular fungal infections with oral fluconazole. American Journal of Ophthalmology (1995) 119:477-481
21. del Palacio A, Cuetara MS, Ferro M, Perez-Blazquez E, Lopez-Sana JA, Roiz M, Carnevali D, Noriega AR: Fluconazole in the management of endophthalmitis in disseminated candidosis of hemm addicts. Mycoses (1993) 36:193-199
22. Edwards JEJ, Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, Ghannoum MA, Glauser M, Herbrecht R, Kauffman CA, Kohno S, Martino P, Meunier F, Mori T, Pfaller MA, Rex JH, Rogers TR, Rubin RH, Solomkin J, Viscoli C, Walsh TJ: International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clinical Infectious Diseases (1997) 25:43-59
23. Nomura J, Ruskin J: Failure of therapy with fluconazole for candidal endophthalmitis. Clinical Infectious Diseases (1993) 17:888-889
24. 125I Hippuran absorption from the human renal pelvis. Journal of Urology (1986) 136:726-732
25. Sonda PL, Fischer PC, Gross MD, Skiner RS: Pyclovenous backflow: implications for coagulium pyelolythotomy and nephroscopy. Journal of Urology (1985) 133:894-896
26. Ryan PC, Lennon GM, McLean PA, Fitzpatrick JM: The effect of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit. British Journal of Urology (1994) 74:434-439
27. Ang BSP, Teleni A, King B, Steckelberg JM, Wilson WR: Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clinical Infectious Diseases (1992) 17:662-666
28. Nicholson ML, Veitek PS, Donnelley PK, Bell PRF: Systemic candidiasis caused by a renal transplant ureteric stent. British Journal of Urology (1992) 70:448-449
29. Wong-Beringer A, Jacobs RA, Guglielmo BJ: Treatment of funguria. Journal of the American Medical Association (1992) 267:2780-2785
30. Gubbins PO, Piscitelli SC, Danziger LH: Candidal urinary tract infections: a comprehensive review of their diagnosis and management. Pharmacotherapy (1993) 13:110-127
31. Gubbins PO, Ochipinti DJ, Danziger LH: Surveillance of treated and untreated funguria in a university hospital. Pharmacotherapy (1994) 14:463-470
32. Goldberg PK, Koznin PJ, Wise GJ, Nouri N, Brooks RB: Incidence and significance of candiduria. Journal of the American Medical Association (1979) 241:582-584
33. Seneca H, Peer P: Clinical laboratory diagnosis of urinary tract infection. Journal of Urology (1965) 94:78-81
34. Anonymous: Urinary tract candidosis. Lancet (1988) 2:1000-1002
35. Nassoura Z, Ivatury RR, Simon RJ, Jabbour N, Stahl WM: Candiduria as an early marker for disseminated infection in critically ill surgical patients: the role of fluconazole therapy. Journal of Trauma (1993) 35:240-295
36. Pittet D, Monod M, Suter PM, Frenk E, Aukenthaler R: Candida colonization and subsequent infection in critically ill surgical patients. Annals of Surgery (1994) 230:751-758
37. Jacobs LG, Skidmore EA, Freeman K, Lipschultz D, Fox N: Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clinical Infectious Diseases (1996) 22:30-35
38. Hsieh-Shong L, Ching-Tai H: Clearance of funguria with short-course antifungal regimens: a prospective randomized, controlled study. Clinical Infectious Diseases (1995) 20:1152-1157
39. Fan-Havard P, O'Donovan C, Smith SM, Oh J, Bamberger M, Eng RHK: Oral fluconazole versus amphotericin B bladder irrigation for treatment of candidal funguria. Clinical Infectious Diseases (1995) 21:960-965
40. Tacker JR: Successful use of fluconazole for treatment of urinary tract fungal infection. Journal of Urology (1992) 148:1917-1918
41. Fisher JF, Newman CL, Sobel JD: Yeast in the urine: solutions for a budding problem. Clinical Infectious Diseases (1995) 20:183-189
42. Como JA, Dismukes WE: Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine (1994) 330:263-272